วิวินาวิ : วอชิงตันดีซี : (สหรัฐอเมริกา) Washington DC

Centers for Medicare & Medicaid Services Quality Payment Program
CY 2025 performance period/2027 MIPS payment year Exclusion Guidance for the Electronic Case Reporting (eCR) Measure

The Centers for Medicare & Medicaid Services (CMS) is providing guidance to clarify language in exclusion 2 for the Electronic Case Reporting (eCR) measure for the Promoting Interoperability performance category of the Merit-based Incentive Payment System (MIPS).

eCR measure details can be found in TABLE 77: Objectives and Measures [ https://links-2.govdelivery.com/CL0/https:%2F%2Fwww.federalregister.gov%2Fd%2F2024-25382%2Fpage-98418/1/0101019528e9bd3b-269dae52-61c9-4ba8-8325-3bd91953f53e-000000/o0F7gsh0J4GLtq4Ts1iTce_sRyafPm7bLCQ7GZpmIWc=393 ] for the MIPS Promoting Interoperability performance category in the CY 2025 Physician Fee Schedule (PFS) final rule.

For your convenience, the eCR measure’s specifications are reproduced below:

*Measure*: The MIPS eligible clinician is in active engagement with a public health agency (PHA) to submit electronic case reporting of reportable conditions.

*Exclusion*: Any MIPS eligible clinician meeting one or more of the following criteria may be excluded from the electronic case reporting measure if the MIPS eligible clinician:

(1) Does not treat or diagnose any reportable diseases for which data are collected by its jurisdiction’s reportable disease system during the performance period;

(2) Operates in a jurisdiction for which no public health agency (PHA) is *capable of receiving eCR data in the specific standards required* to meet the certified electronic health record technology (CEHRT) definition at the start of the performance period; or

(3) Operates in a jurisdiction where no PHA has declared readiness to receive eCR data as of 6 months prior to the start of the performance period.

For MIPS, the CEHRT definition is set forth in 42 C.F.R. 414.1305 [ https://links-2.govdelivery.com/CL0/https:%2F%2Fwww.ecfr.gov%2Fcurrent%2Ftitle-42%2Fchapter-IV%2Fsubchapter-B%2Fpart-414%2Fsubpart-O%2Fsection-414.1305/1/0101019528e9bd3b-269dae52-61c9-4ba8-8325-3bd91953f53e-000000/Kib6G_l5DAS7UxoAN3kRgOSAAirH0Z4vjCdkd5QqZ8g=393 ].

In the CY 2023 PFS final rule (87 FR 70071 – 70074) [ https://links-2.govdelivery.com/CL0/https:%2F%2Fwww.federalregister.gov%2Fd%2F2022-23873%2Fpage-70071/1/0101019528e9bd3b-269dae52-61c9-4ba8-8325-3bd91953f53e-000000/g4KqkAEhnY6tAnDzU4Jfox9NuFSu8UlQXpnSAv00Mb8=393 ], CMS finalized that, beginning with the CY 2024 performance period, MIPS eligible clinicians may spend only one performance period at the Pre-production and Validation (Option 1) level of active engagement, and that they must progress to the Validated Data Production (Option 2) level of active engagement in the next performance period for which they report the eCR measure. In the CY 2023 PFS final rule, CMS finalized its definition of the Validated Data Production (Option 2) level of active engagement as the MIPS eligible clinician having completed testing and validation of the electronic submission and is electronically submitting production data for the eCR measure to the PHA or clinical data registry (CDR).

Based on these finalized requirements, CMS interprets *“capable of receiving eCR data in the specific standards required”* in Exclusion (2) to mean no PHA in the MIPS eligible clinician’s jurisdiction has the ability to advance, and has advanced, the MIPS eligible clinician registered with the PHA to Active Engagement Option 2: Validated Data Production in the timeframe required for the MIPS eligible clinician to achieve Validated Data Production under the MIPS Promoting Interoperability performance category.

CMS encourages MIPS eligible clinicians to use the exclusions for the eCR measure, as appropriate, when reporting data for the MIPS Promoting Interoperability performance category for the CY 2025 performance period and subsequent years in the Quality Payment Program (QPP) [ https://links-2.govdelivery.com/CL0/https:%2F%2Fqpp.cms.gov%2Flogin/1/0101019528e9bd3b-269dae52-61c9-4ba8-8325-3bd91953f53e-000000/12nwdWmwqqHy5luGo19RrmvbNBY_JEof2D5qbwGw7OI=393 ]. The system is open for performance category related submissions between January 2, 2025, through March 31, 2025, unless otherwise specified by CMS. A similar announcement will be shared with eligible hospitals and Critical Access Hospitals (CAHs) participating in the Medicare Promoting Interoperability Program.

*For More Information*

For more information on the Promoting Interoperability performance category, visit the QPP website [ https://links-2.govdelivery.com/CL0/https:%2F%2Fqpp.cms.gov%2Fmips%2Fpromoting-interoperability/1/0101019528e9bd3b-269dae52-61c9-4ba8-8325-3bd91953f53e-000000/QVqugr5ma-T-xatnf3-23Noy02LRPA0ywQM3uGUhP10=393 ].

For more information on electronic case reporting, visit www.cdc.gov/ecr [ https://links-2.govdelivery.com/CL0/https:%2F%2Fwww.cdc.gov%2Fecr/1/0101019528e9bd3b-269dae52-61c9-4ba8-8325-3bd91953f53e-000000/fURYDzy3kWPG46QUvV6ruvnDAiLeuQMkfVrO-MsQJag=393 ].

QPP Footer 2023 [ https://qpp.cms.gov/resources/help-and-support ]


________________________________________________________________________

You're getting this message because you subscribed to get email updates from the Centers for Medicare & Medicaid Services (CMS) [ http://www.cms.gov/ ].

Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page [ https://public.govdelivery.com/accounts/USCMS/subscriber/edit?preferences=true#tab1 ]. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com [ https://subscriberhelp.govdelivery.com/ ].

This service is provided to you at no charge by Centers for Medicare & Medicaid Services (CMS) [ http://www.cms.gov ].


________________________________________________________________________

This email was sent to mshinji3056@gmail.com using GovDelivery Communications Cloud 7500 Security Boulevard · Baltimore MD 21244


body .abe-column-block { min-height: 5px; } table.gd_combo_table img {margin-left:10px; margin-right:10px;} table.gd_combo_table div.govd_image_display img, table.gd_combo_table td.gd_combo_image_cell img {margin-left:0px; margin-right:0px;} table.govd_hr {min-width: 100%;}